1.
TH Open
; 6(3): e154-e155, 2022 Jul.
Artículo
en Inglés
| MEDLINE
| ID: mdl-36046207
RESUMEN
Emicizumab constitutes a novel and effective prophylaxis for hemophilia A patients with and without inhibitors. In this case report, we describe an emicizumab-induced photosensitivity that forced permanent sun-exposure suppression. To the best of our knowledge, this side effect had not been communicated until present.